![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety and Efficacy of 2 mg Bulevirtide in Patients with Chronic HBV/HDV Co-Infection:
First Real-World Results
French Early Access Program
|
|
|
Victor de Lédinghen, Dominique Guyader, Sophie Métivier, Marie-Noëlle Hilleret, Hélène Fontaine, Bruno Roche, Nathalie Ganne-Carrié, Louis d'Alteroche, Véronique Loustaud-Ratti, Anne Gervais, Christiane Stern, Laurent Alric, Isabelle Fouchard-Hubert, Tarik Asselah, Karine Lacombe, Fabien Zoulim, Jérôme Dumortier, Anne Minello, Caroline Lascoux-Combe, Léon Muti, Isabelle Ollivier-Hourmand, Dominique Larrey, Vincent Leroy, Isabelle Rosa, Julie Chas, Frédéric Heluwaert, Patrick Borentain, Isabelle Archambeaud, Bernard Prouvost-Keller, Si Nafa Si Ahmed, Dominique Roulot
French collaborative study. Bordeaux, Rennes, Toulouse, Grenoble, Paris, Tours, Limoges, Angers, Lyon, Dijon, Clermont-Ferrand, Montpellier, Caen, Annecy, Marseille.
![1113211](../images/111321/111321-3/1113211.gif)
![1113212](../images/111321/111321-3/1113212.gif)
![1113213](../images/111321/111321-3/1113213.gif)
![1113214](../images/111321/111321-3/1113214.gif)
![1113215](../images/111321/111321-3/1113215.gif)
![1113216](../images/111321/111321-3/1113216.gif)
![1113217](../images/111321/111321-3/1113217.gif)
![1113218](../images/111321/111321-3/1113218.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|